HER2-positive gastric adenocarcinoma is a subtype of stomach cancer characterized by the overexpression of the HER2 (human epidermal growth factor receptor 2) protein. This aggressive…
Gastric and gastroesophageal junction (GEJ) adenocarcinomas are aggressive malignancies with limited treatment options. Recent advancements have identified CLDN18.2 as a promising biomarker in patients with…